|
Cue Biopharma, Inc. (sugestão) Avaliação DCF |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Cue Biopharma, Inc. (CUE) Bundle
Explore o futuro financeiro da Cue Biopharma, Inc. (CUE) com nossa calculadora DCF amigável! Digite suas suposições sobre crescimento, margens e custos para calcular o valor intrínseco da Biopharma e refine sua abordagem de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.2 | 14.9 | 1.2 | 5.5 | 9.3 | 13.4 | 19.4 | 27.9 | 40.3 | 58.3 |
| Revenue Growth, % | 0 | 373.68 | -91.67 | 340.88 | 69.16 | 44.37 | 44.37 | 44.37 | 44.37 | 44.37 |
| EBITDA | -44.0 | -45.4 | -50.5 | -46.1 | -41.5 | -13.4 | -19.4 | -27.9 | -40.3 | -58.3 |
| EBITDA, % | -1394.44 | -304.15 | -4054.72 | -838.83 | -446.86 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.1 | -1.8 | 1.8 | 3.4 | .0 | 4.9 | 7.1 | 10.3 | 14.8 | 21.4 |
| Depreciation, % | 33.52 | -11.9 | 145.04 | 62.59 | -0.32303 | 36.78 | 36.78 | 36.78 | 36.78 | 36.78 |
| EBIT | -45.0 | -43.7 | -52.3 | -49.5 | -41.5 | -13.4 | -19.4 | -27.9 | -40.3 | -58.3 |
| EBIT, % | -1427.96 | -292.25 | -4199.76 | -901.42 | -446.54 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 84.9 | 64.4 | 76.3 | 48.5 | 22.5 | 13.4 | 19.4 | 27.9 | 40.3 | 58.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.4 | 3.1 | .1 | 1.7 | .9 | 3.0 | 4.3 | 6.2 | 9.0 | 13.0 |
| Account Receivables, % | 44.94 | 21.03 | 4.6 | 30.93 | 10.18 | 22.33 | 22.33 | 22.33 | 22.33 | 22.33 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0.000006692827 | 0.000080306643 | 0 | 0 | 0.000017399894 | 0.000017399894 | 0.000017399894 | 0.000017399894 | 0.000017399894 |
| Accounts Payable | 2.1 | 2.6 | 2.7 | 3.5 | 2.8 | 7.4 | 10.7 | 15.5 | 22.4 | 32.3 |
| Accounts Payable, % | 65.63 | 17.34 | 219.32 | 63.77 | 30.4 | 55.43 | 55.43 | 55.43 | 55.43 | 55.43 |
| Capital Expenditure | -.6 | -.9 | -.2 | .0 | -.1 | -1.1 | -1.5 | -2.2 | -3.2 | -4.6 |
| Capital Expenditure, % | -18.87 | -6.11 | -13.71 | 0 | -0.71067 | -7.88 | -7.88 | -7.88 | -7.88 | -7.88 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -45.3 | -44.2 | -52.1 | -49.5 | -41.5 | -13.4 | -19.3 | -27.9 | -40.3 | -58.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -44.1 | -48.1 | -47.2 | -46.9 | -41.5 | -7.0 | -11.8 | -17.0 | -24.6 | -35.4 |
| WACC, % | 12.91 | 12.91 | 12.9 | 12.91 | 12.91 | 12.91 | 12.91 | 12.91 | 12.91 | 12.91 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -61.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -36 | |||||||||
| Terminal Value | -332 | |||||||||
| Present Terminal Value | -181 | |||||||||
| Enterprise Value | -242 | |||||||||
| Net Debt | -14 | |||||||||
| Equity Value | -229 | |||||||||
| Diluted Shares Outstanding, MM | 56 | |||||||||
| Equity Value Per Share | -4.06 |
What You Will Get
- Comprehensive CUE Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Cue Biopharma's future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Data Access: Cue Biopharma's historical financial records and pre-filled projections.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: View Cue Biopharma's intrinsic value update instantly.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based CUE DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically updates Cue Biopharma’s intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation changes.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator?
- Accurate Data: Real Cue Biopharma financials ensure reliable valuation results.
- Customizable: Adjust key parameters like growth rates, WACC, and tax rates to align with your projections.
- Time-Saving: Pre-built calculations save you from starting from scratch.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants.
- User-Friendly: Intuitive design and step-by-step guidance make it accessible for all users.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Cue Biopharma, Inc. (CUE) stock.
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for Cue Biopharma, Inc. (CUE).
- Consultants: Provide clients with expert valuation insights on Cue Biopharma, Inc. (CUE) quickly and accurately.
- Business Owners: Gain insights into how biopharmaceutical companies like Cue Biopharma, Inc. (CUE) are valued to inform your own business strategies.
- Finance Students: Explore valuation techniques using real-world data and scenarios related to Cue Biopharma, Inc. (CUE).
What the Template Contains
- Historical Data: Includes Cue Biopharma’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Cue Biopharma’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Cue Biopharma’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.